Vertex Pharmaceuticals About
Vertex Pharmaceuticals: Vertex Pharmaceuticals Incorporated
is a global biotechnology company focused on the discovery, development and commercialization
of breakthrough drugs for a range of serious diseases. Vertex co-promotes
with GlaxoSmithKline the new HIV protease inhibitor, Lexiva®, in the United
States and Agenerase® in Europe. Vertex and Merck are collaborating on the discovery
and development of Aurora kinase inhibitors, which hold the potential to
play a major role for the treatment of a wide range of cancers. In North
America, Vertex's product pipeline is principally focused on viral diseases,
inflammation,
autoimmune diseases, and cancer. VX-385 -- HIV
infection Merimepodib -- hepatitis
C VX-950 -- hepatitis
C VX-765 -- cytokine
inhibitor of interleukin-1 beta converting enzyme (ICE) VX-702 --
acute coronary syndromes Pralnacasan -- inflammatory diseases VX944,
VX630 -- Cancer More
on
Vertex Key
Statistics for Vertex
Basic
Chart for Vertex